Business Context and Reporting Period
This Form 8-K was filed by Apimeds Pharmaceuticals US, Inc. (APUS) on March 26, 2026, reporting events occurring on March 20, 2026. The filing addresses a corporate governance dispute involving a purported stockholder consent submitted by Inscobee Inc. and Apimeds, Inc. (Apimeds Korea) attempting to remove the Company's Board of Directors and executive officers.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on legal and governance matters rather than financial performance.
Material Changes and Corporate Actions
- Invalid Stockholder Consent: The Company declared a "Stockholder Consent" dated March 20, 2026, as null and void. The consent attempted to remove all directors (Elona Kogan, Jakap Koo, Carol O'Donnell, Dr. Bennett Weintraub) and officers (Dr. Vin Menon, CEO; Mr. Erick Frim, CFO).
- Breach of Support Agreement: The Company asserts the consent violated a binding Stockholder Support and Lock-Up Agreement related to a pending Merger with MindWave Innovations Inc. The agreement granted the Company an irrevocable proxy over 6,416,365 shares held by Inscobee and Apimeds Korea.
- Legal Standing: The Company states that without the 6,416,365 shares subject to the irrevocable proxy, the consent lacked the requisite majority under Delaware law. Consequently, the existing Board and officers remain in their positions.
- Unauthorized Business Initiatives: Alleged replacement directors announced unauthorized memoranda of understanding with Assemble Corporation, Hilluck Co. Ltd., and LK Ventures Co., Ltd. The Company does not recognize these actions.
Guidance, Outlook, and Risks
- Legal Action: The Company intends to petition the Delaware Court of Chancery to obtain a declaration that the Stockholder Consent is void and to enforce its rights under the Support Agreement.
- Merger Status: The Company and MindWave Innovations Inc. remain committed to completing the Merger Agreement dated December 1, 2025.
- Risk Warning: The Company cautions third parties that relying on the purported Stockholder Consent or the unauthorized business initiatives is done at their own risk, as such actions may be invalid and subject to reversal.
- Forward-Looking Statements: The filing includes standard disclaimers regarding risks and uncertainties that could cause actual results to differ from expectations.
Key Facts for Investor Verification
- Verify the current status of the Delaware Court of Chancery petition regarding the validity of the March 20, 2026 Stockholder Consent.
- Confirm the continued validity of the Merger Agreement with MindWave Innovations Inc. and the irrevocable proxy over 6,416,365 shares.
- Monitor for any official announcements regarding the unauthorized joint ventures with Assemble Corporation, Hilluck Co. Ltd., and LK Ventures Co., Ltd.
- Check subsequent filings to ensure the Board composition remains unchanged as asserted by the Company.